Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7898-7903, Vol. 69, No. 12
School of Life Sciences, Jawaharlal Nehru
University, New Delhi 110067, India
Received 23 May 2001/Returned for modification 10 July
2001/Accepted 2 August 2001
A Candida albicans mutant with mutations in the
N-acetylglucosamine (GlcNAc) catabolic pathway gene
cluster, including the GlcNAc-6-phosphate deacetylase
(DAC1), glucosamine-6-phosphate deaminase
(NAG1), and GlcNAc kinase (HXK1) genes,
was not able to grow on amino sugars, exhibited highly attenuated
virulence in a murine systemic candidiasis model, and was less adherent to human buccal epithelial cells in vitro. No germ tubes were formed by
the mutant after induction with GlcNAc, but the mutant exhibited
hyperfilamentation under stress-induced filamentation conditions. In
addition, the GlcNAc catabolic pathway played a vital role in
determining the colony phenotype. Our results imply that this pathway
is very important because of its diverse links with pathways involved
in virulence and morphogenesis of the organism.
Candida albicans, which
causes life-threatening superficial and systemic candidiasis in
immunocompromised hosts, can invade and colonize human mucosal surfaces
rich in amino sugars (29, 44). The unique ability of the
pathogenic Candida species to utilize amino sugars like
N-acetylglucosamine (GlcNAc) and glucosamine (GlcN) as
alternate carbon sources (37) led us to surmise that there
is a correlation between such specific adaptation and the virulence of
the organism. Besides inducing enzymes of the catabolic pathway, GlcNAc
can also induce cellular morphogenesis in C. albicans, and
dimorphism is suspected to be an important aspect of manifestation of
infection (21, 24). The amino sugar catabolic pathway in C. albicans was elucidated previously (3, 27, 31,
36), and the terminal enzyme of the GlcNAc catabolic pathway,
glucosamine-6-phosphate deaminase (encoded by NAG1), was
cloned in our laboratory (22, 28) in order to investigate
the importance of this pathway. Here we describe disruption of the
GlcNAc catabolic pathway and establish direct correlations of this
pathway with virulence, adhesion, and morphogenesis of C. albicans. All animal experiments in this study were performed in
accordance with the rules of the Institutional Animals Ethics Committee
(JNU-IAEC code 9/1999).
Both copies of NAG1 were disrupted in
Ura
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7898-7903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Attenuation of Virulence and Changes in Morphology
in Candida albicans by Disruption of the
N-Acetylglucosamine Catabolic Pathway
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
C. albicans wild-type strain
CAF3-1 (13) by the Ura-blaster technique
(13). The targeting construct for disruption was made in
parental genomic clone pED4 (22), in which the 1.94-kb
NcoI fragment housing the NAG1 open reading
frame, part of the bidirectional promoter (22), and the
downstream region was replaced with the 4.01-kb BamHI-BglII fragment from pCUB6 (13)
containing the hisG-URA3-hisG cassette (Fig.
1A). CAF3-1 was
transformed by the spheroplast method (39) with the
5.97-kb SalI fragment derived from the targeting construct.
Transformants were selected on synthetic minimal medium (SD medium)
plates (0.67% yeast nitrogen base [YNB] without amino acids, 2%
dextrose, 2% agar) to obtain Ura+ transformants.
After confirmation of disruption by Southern analysis (Fig. 1B), a
Ura+ transformant (N-2) was screened for
Ura-cured segregants on 5-FOA plates (4). A
Ura
mutant (N-2-1) (Fig. 1B) was transformed
with the 5.97-kb SalI fragment to disrupt the second copy of
NAG1 by using a similar process in order to generate the
homozygous mutants N-2-1-6 (Ura+) and N-2-1-6-1
(Ura
). For Southern analysis of genotypes,
genomic DNAs isolated (18) from the transformants were
digested with SalI (1 to 2 µg of DNA), and hybridization
was performed at 42°C by using a 32P-labeled
3.91-kb SalI fragment from pED4 as the probe. The genotypes of all of the mutants generated in this study are shown in Table 1.

View larger version (43K):
[in a new window]
FIG. 1.
Disruption of GlcNAc catabolic pathway gene cluster in
C. albicans. (A) Schematic diagram showing the genomic
organization of the DAC1NAG1HXK1 gene cluster in the
3.91-kb SalI fragment of pED4. The restriction sites are
indicated as follows: S, SalI; N, NcoI;
BH, BamHI; Bg, BglII. The 1.94-kb
NcoI fragment was replaced by the 4.01-kb
hisG-URA3-hisG cassette from pCUB6. The resultant
5.97-kb SalI fragment was used as the disruption
cassette. (B) Southern blot of SalI-digested genomic DNA
from wild-type and mutant derivatives, showing sequential disruption of
both copies of the cluster for wild-type strain CAF3-1
(DAC1NAG1HXK1/DAC1NAG1HXK1 ura3), N-2
(DAC1NAG1HXK1/dac1nag1hxk1 URA3), N-2-1
(DAC1NAG1HXK1/dac1nag1hxk1 ura3), N-2-1-6
(dac1nag1hxk1/dac1nag1hxk1 URA3), and
N-2-1-6-1 (dac1nag1hxk1/dac1nag1hxk1
ura3). When the first allele of
DAC1NAG1HXK1 was disrupted, the 3.91-kb
SalI fragment of the undisrupted allele gave rise to a
5.97-kb SalI fragment as a result of integration of the
disruption cassette by homologous recombination, as seen in N-2. Curing
of URA3 resulted in loss of the
hisG-URA3 fragment and in a smaller, 3-kb
SalI fragment, as seen in N-2-1. Integration of the
5.97-kb SalI disruption cassette in N-2-1 resulted in
two SalI fragments, which were 5.97 and 3 kb long, as
seen in N-2-1-6. Curing of URA3 in this homozygous
mutant resulted in two 3-kb SalI fragments. (C)
hisG-URA3-hisG cassette inserted at the
NcoI site downstream of NAG1, shown in
construct P-33. (D) Southern blot of SalI-digested
genomic DNA of N-2-1-6-1+P-33 (DAC1NAG1hxk1/dac1nag1hxk1
URA3). The 7.9-kb SalI cassette of P-33
was integrated into N-2-1-6-1. (E) Southern blot of
SalI-digested genomic DNA of final revertant P-4. The
3.91-kb SalI fragment of pED4 was integrated into
N-2-1-6. In panels B, D, and E, the 3.91-kb SalI
fragment from pED4 was the probe. In panels D and E, the 3.91-kb
SalI fragment from wild-type CAF3-1 was the marker. (F)
Growth of wild type and mutants on glucose and amino sugars at 30°C.
Sector 1, SC5314 (wild type, Ura+); sector 2, N-2
(heterozygous mutant); sector 3, N-2-1-6 (homozygous mutant); sector 4, N-2-1-6-1+P-33
(hxk1 mutant); sector 5, P-4 (heterozygous revertant).
Note that the hxk1 mutant was not able to grow on
GlcN.
TABLE 1.
C. albicans strains used in this work
When homozygous mutant N-2-1-6 was checked for growth on glucose (SD medium), GlcNAc (0.67% YNB, 2% GlcNAc, 2% agar), and GlcN (0.67% YNB, 2% GlcN, 2% agar) at 30°C, it was not able to grow on amino sugars (Fig. 1F), while no growth defect was observed in the case of the Ura+ parental control (SC5314) (16) and heterozygous mutant (N-2) strains. Growth at 37°C exhibited a similar pattern (data not shown).
In the process of NAG1 disruption, the GlcNAc-6-phosphate deacetylase (DAC1) gene was also functionally impaired because it shares a bidirectional promoter with NAG1 (Fig. 1A). In order to create a revertant, a construct was made by inserting the hisG-URA3-hisG cassette at the NcoI site downstream of NAG1 in pED4 (Fig. 1C). The 7.9-kb SalI fragment from recombinant P-33 was integrated into the genome of homozygous mutant N-2-1-6-1 by using the spheroplast method of transformation, and it was checked by Southern analysis (Fig. 1D). The 3.91-kb SalI fragment from pED4 was used as the probe. The revertant generated, N-2-1-6-1+P-33, with functional DAC1 and NAG1 genes, failed to restore growth on GlcNAc (Fig. 1F), indicating that the region downstream of NAG1 contained a gene important for catabolism. A BLAST homology search of the National Center for Biotechnology Information website disclosed the presence of a hexokinase (HXK1) gene in the cluster along with DAC1 and NAG1 (22). Although clusters of functionally related genes are less prevalent in eukaryotes, it has often been reported that genes for dispensable metabolic pathways in fungi are organized in clusters. Our data establish, for the first time, that there is a gene cluster in C. albicans (22). The inability of the hxk1 mutant (N-2-1-6-1+P-33) to grow on GlcNAc suggests that HXK1 is the GlcNAc kinase gene. This mutant surprisingly did not grow on GlcN. It has been hypothesized that GlcN is phosphorylated by a different kinase (43), but the failure of the hxk1 mutant to grow on GlcN suggests that the same kinase is responsible for phosphorylation of both GlcNAc and GlcN. The inability of the homozygous mutant to grow on GlcNAc and GlcN also established that this is the sole pathway for utilization of amino sugars. To restore function, revertant P-4, which was heterozygous for the DAC1, NAG1, and HXK1 genes, was created by integrating the SalI fragment from pED4 into the genome of N-2-1-6. Transformants were selected on GlcNAc plates, and integration was confirmed by Southern analysis (Fig. 1E). P-4 restored growth on amino sugars (Fig. 1F).
The GlcNAc catabolic pathway of C. albicans is very similar to that of Escherichia coli, in which both GlcNAc and GlcN can induce the Nag regulon (30). Besides E. coli, utilization of GlcNAc has also been reported for other pathogenic bacteria, such as Klebsiella pneumoniae and Vibrio cholerae. Therefore, development of the amino sugar catabolic pathway during evolution could be a common feature of many pathogens.
In addition to its role as a carbon and nitrogen source, GlcNAc can
induce cellular morphogenesis in C. albicans
(34). After induction with 2.5 mM GlcNAc at 37°C in salt
base (0.335% YNB, 0.45% NaCl) (38), homozygous mutant
N-2-1-6 stayed in the yeast form, and there was a total lack of
formation of germ tubes; in contrast, wild-type strain SC5314 formed
profuse germ tubes (Fig. 2). Heterozygous
mutant N-2 and revertant P-4 exhibited no defect in germ tube formation
and formed elongated germ tubes similar to those of SC5314 (Fig. 2).
Formation of germ tubes is accompanied by heavy aggregation of cells
(34), but unlike the wild-type, heterozygous mutant, and
revertant strains, the homozygous mutant failed to form aggregates
after induction with GlcNAc, as determined visually (data not shown).
|
Since transport of GlcNAc inside cells is not necessary for germ tube induction (35), the total lack of germ tube formation by the mutant is an interesting phenomenon. We hypothesize that disruption of the pathway probably disturbed the cell surface receptor(s) responsible for reception or transmission of signals. It would be interesting to identify the link between the catabolic pathway and cellular signaling.
It has been suspected for a long time that dimorphism is a mechanism of virulence (21). The effect of the disruption on colony morphology was studied by using previously described media, such as SLAD (17) and Spider medium (23). Cells of SC5314, N-2, N-2-1-6, and P-4 were grown in SD medium at 30°C for 2 days, counted with a hemocytometer, plated on SLAD plates (0.17% YNB without amino acids and ammonium sulfate, 2% dextrose, 2% Bacto Agar [Difco], 50 µM ammonium sulfate) at a concentration of 80 to 100 cells per plate, and incubated at 37°C for 10 days. For induction on Spider medium plates (1% nutrient broth, 1% mannitol, 0.2% K2HPO4, 1.35% Bacto Agar; pH 7.2 after autoclaving), the cells were grown in Spider medium for 5 days at 30°C, counted, plated at a concentration of 80 to 100 cells per plate, and incubated at 37°C for 7 days.
Homozygous mutant N-2-1-6 exhibited a novel pattern of filamentation consisting of very extensive ramified filaments on SLAD plates (Fig. 2). A dramatic change in colony phenotype was observed on Spider medium plates that had extensive filamentation; there was an unusual irregular wrinkled colony surface consisting of entangled hyphae (Fig. 2). The hyperfilamentation displayed by N-2-1-6 on SLAD and Spider medium plates established, for the first time, the role of the GlcNAc signaling pathway in morphogenesis of C. albicans under stress-induced conditions. However, heterozygous mutant N-2 and revertant P-4 did not produce an intermediate filamentation pattern, and they exhibited a highly compromised state of filamentation, suggesting that gene dosage is important for morphogenesis of C. albicans under certain inducing conditions, a phenomenon that was observed in previous studies (14).
Hyperfilamentation could be the result of derepression of a repressor like RBF1 (20) or TUP1 (5); mutants with mutations in these genes exhibit excessive filamentation. Alternatively, the pathway could act coordinately with components of the mating hyphal mitogen-activated protein kinase pathway (11, 25), with Efg1p, an essential regulator of filamentation that acts downstream of the Ras-cAMP-Tpk2p pathway (24, 38, 40), or with other pathway components involved in morphogenesis and virulence (8). In addition, the GlcNAc catabolic pathway also plays a role in determining colony surface morphology that could be mediated by one of the signaling pathways mentioned above.
To investigate the role of the GlcNAc catabolic pathway in the
virulence of C. albicans, hematogenously disseminated
candidiasis was studied in the BALB/c mouse model (1, 9,
11). Female mice (age, 8 to 10 weeks; body weight, 18 to 20 g) were used in groups of eight per dose per strain. Wild-type
(SC5314), homozygous mutant (N-2-1-6), and revertant (P-4) cells were
grown on YPD (1% yeast extract, 2% peptone, 2% dextrose) plates at
30°C for 48 h, washed twice with phosphate-buffered saline
(PBS), and counted, and an aliquot plated on YPD was grown overnight to
determine the number of CFU. Doses containing 106
CFU per 200 µl of PBS were prepared, and mice were injected
intravenously through the lateral tail vein. When the homozygous mutant
was used, none of the mice died by day 25, but when the wild type was
used, all of the mice died by day 11. The virulence of the revertant was less than that of the wild-type strain, and 25% of the
mice survived to the end of the experiment (Fig.
3A). The doses of the
homozygous mutant used in the experiments and the length of the period
for which survival of the mice was monitored indicated that the
virulence of the homozygous mutant was highly attenuated.
|
C. albicans in systemic infections is known to infect vital
organs, and for some unexplained reason kidneys are the most
conspicuously affected organ. The fungal loads recovered from mouse
kidneys infected with wild-type, homozygous mutant, and revertant
strains are shown in Table 2. Mice were
divided into groups of four animals per strain per time point, and an
inoculum consisting of 106 CFU in 200 µl of PBS
was injected into the lateral tail vein of each mouse. Chloroformed
mice were euthanatized by cervical dislocation after 24, 48, and
72 h. The kidneys were removed, weighed, and crushed in sterile
mortars with sterile pestles in 5 ml of PBS. Dilutions were prepared,
and aliquots were plated on YED-chloramphenicol plates (1% yeast
extract, 2% dextrose, 2% agar, 5 µg of chloramphenicol per ml) and
incubated at 30°C for 2 days. Colonies were counted, the numbers of
CFU per gram of tissue were determined, and the values were expressed
in terms of log10 CFU. The
mice infected with wild-type and revertant strains had very high fungal
loads in their kidneys 24 h postinfection, as shown by the high
number of CFU that rapidly increased (Table 2). The mice inoculated
with the homozygous mutant had a strikingly low fungal burden on the
first day, and the number of organisms recovered after 72 h was
lower (Table 2). The trend towards renal clearance observed in mice
infected with the homozygous mutant clearly indicates that a functional
GlcNAc catabolic pathway in C. albicans is essential for
colonization of the target organs.
|
To find out more about the behavior of the homozygous mutant in vivo, histopathological studies were conducted by using 106 CFU with groups of four mice per strain. Kidneys removed 24 h postinfection were fixed in 10% formaldehyde-PBS, sectioned (thickness, 6 µm) in paraffin blocks, and stained with periodic acid-Schiff reagent by using conventional procedures. The sections revealed huge focal collections of Candida cells in the case of wild-type and revertant strains (Fig. 3B). In contrast, the area infected by the mutant strain was very small, but the mutant formed mycelia like those of the wild type (Fig. 3B). From the results we determined that the loss of virulence was not due to a defect in filamentation.
The possibility that virulence was lost because of retarded growth of the homozygous mutant was ruled out by determining the growth rates of the wild-type, homozygous mutant, and revertant strains in YPD at 30°C, in 2× YPD at 37°C (24), and in serum at 37°C (in vitro) by measuring the rates of glucose consumption (15). No significant difference in the growth rates was observed in any case (data not shown).
The virulence of Candida species is closely correlated with
the ability of the organisms to adhere to cells in vitro (7, 33). We speculated that the initial low numbers of fungus cells recovered from kidneys infected with the homozygous mutant could have
been due to a lower ability of the mutant to adhere to endothelial cells in vivo, resulting in rapid clearance from the blood. We examined
the abilities of SC5314, N-2-1-6, and P-4 to adhere to human buccal
epithelial cells (HBEC) in vitro by performing a visual assay
(2). The strains were grown on YPD plates at 30°C for 2 days and washed with 0.02 M PBS (0.02 M NaCl, 0.15 M
Na2HPO4; pH 7.2), and the
cells were counted. HBEC from three male and female volunteers (ages,
28 to 31 years) were washed with 0.02 M PBS and counted. A total of
107 Candida cells were incubated with
105 HBEC in 0.02 M PBS at 37°C for 1 h.
The cells were then passed through 12-µm-pore-size filters obtained
from SPI Supplies and washed with 0.02 M PBS. The contents of the
filters were transferred to microscope slides and stained with crystal
violet. The total number of Candida cells adhering to 100 HBEC was determined. The experiment was repeated three times, and a
statistical analysis (standard error of the mean) was done with
GraphPad Prism 2.01 software. The number of C. albicans cells that adhered per HBEC was considerably lower in the
case of the homozygous mutant (42.7% reduction compared to the wild
type) (Fig. 4), which partially accounts
for the loss of virulence.
|
Our results demonstrate that C. albicans requires a functional GlcNAc catabolic pathway to become successfully established in systemic infections. We considered the many factors that are responsible for the virulence of this organism and examined the possible alterations that might have resulted in attenuation of virulence in a homozygous mutant. Although there is no compelling evidence that filamentation plays a definite role in virulence, it is widely believed that the two events are correlated, as many mutants defective in in vitro filamentation are also less virulent in systemic infections (11, 24). However, C. albicans cells recovered from lesions have both yeast and filamentous forms, suggesting that both forms are important for virulence. It has been observed that an efg1 cph1 double mutant that is not filamentous under most in vitro induction conditions and exhibits highly attenuated virulence in mouse systemic infections retains the ability to form filaments at sites of infection (24, 32). On the other hand, a cpp1 mutant is hyperfilamentous in vitro but is not hypervirulent; rather, it displays attenuated virulence in mouse systemic infections (10). Our studies show that a homozygous mutant with a mutation in the GlcNAc catabolic pathway is highly attenuated in terms of virulence, although there is no defect in in vivo filamentation. Whether filamentation plays an important role in virulence remains a moot point, but from our results it appears that the GlcNAc catabolic pathway may not be important for filamentation in serum. This was further shown by in vitro filamentation of the homozygous mutant in serum, which exhibited no defect (data not shown). There is no known interaction of this pathway with RAS1, which is important for filamentation in serum (12) and possibly under many other filament-inducing conditions. Filamentation may not be an important attribute in conferring virulence to the organism but could be a process that is regulated concurrently with many factors that play important roles in virulence.
The possibility that the GlcNAc catabolic pathway is important as a source of carbon in vivo can be ruled out because glucose is available to the cells in serum. In addition, a recent report showed that a GlcNAc concentration of less than 10 µM in serum was not sufficient to support growth of the organism (26). The importance of the GlcNAc catabolic pathway probably lies in the diverse link that it establishes with mechanisms involved in production of different virulent factors, which could be adhesins (41) or hydrolytic enzymes (19, 42). The possibility that there is a defect in cell wall or cell surface structure which leads to a loss of virulence should also be considered since GlcNAc is polymerized into chitin, an integral component of the cell wall (6). It would be very interesting to investigate the prospective routes of the GlcNAc catabolic pathway regulating virulence and morphogenetic signaling in C. albicans.
| |
ACKNOWLEDGMENTS |
|---|
Praveen Singh and Sharmistha Ghosh contributed equally to this work.
We thank William A. Fonzi for providing plasmid pCUB6 and strains SC5314 and CAF3-1.
This work was supported by a grant from the Department of Biotechnology, India.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: 105 Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India. Phone: 0091-11-616-2016, 0091-11-610-7676, and 0091-11-616-7557, ext. 2560 and 2001. Fax: 0091-11-619-8234. E-mail: adatta{at}jnuniv.ernet.in and asisdatta{at}hotmail.com.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Alonso-Monge, R.,
F. Navarro-Garcia,
G. Molero,
R. Diez-Orejas,
M. Gustin,
J. Pla,
M. Sanchez, and C. Nombela.
1999.
Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans.
J. Bacteriol.
181:3058-3068 |
| 2. | Bailey, A., E. Wadsworth, and R. Calderone. 1995. Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signaling events. Infect. Immun. 63:569-572[Abstract]. |
| 3. | Bhattacharya, A., M. Puri, and A. Datta. 1974. Induction of N-acetylglucosamine kinase in yeast. Biochem. J. 141:593-595[Medline]. |
| 4. | Boeke, J. D., F. LaCroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197:345-346[CrossRef][Medline]. |
| 5. |
Braun, B. R., and A. D. Johnson.
1997.
Control of filament formation in Candida albicans by the transcriptional repressor TUP1.
Science
277:105-109 |
| 6. |
Braun, P. C., and R. A. Calderone.
1978.
Chitin synthesis in Candida albicans: comparison of yeast and hyphal forms.
J. Bacteriol.
133:1472-1477 |
| 7. | Calderone, R. A. 1993. Molecular interactions at the interface of Candida albicans and host cells. Arch. Med. Res. 24:275-279[Medline]. |
| 8. | Calera, J. A., and R. Calderone. 1999. Histidine kinase, two-component signal transduction proteins of Candida albicans and the pathogenesis of candidosis. Mycoses 42:49-53. |
| 9. |
Calera, J. A.,
X. J. Zhao, and R. Calderone.
2000.
Defective hyphal development and avirulence caused by a deletion of the SSK1 response regulator gene in Candida albicans.
Infect. Immun.
68:518-525 |
| 10. |
Csank, C.,
C. Makris,
S. Meloche,
K. Schröppel,
M. Röllinghoff,
D. Dignard,
D. Y. Thomas, and M. Whiteway.
1997.
Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans.
Mol. Biol. Cell
8:2539-2551 |
| 11. |
Csank, C.,
K. Schröppel,
E. Leberer,
D. Harcus,
O. Mohamed,
S. Meloche,
D. Y. Thomas, and M. Whiteway.
1998.
Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis.
Infect. Immun.
66:2713-2721 |
| 12. |
Feng, Q.,
E. Summers,
B. Guo, and G. Fink.
1999.
Ras signaling is required for serum-induced hyphal differentiation in Candida albicans.
J. Bacteriol.
181:6339-6346 |
| 13. | Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728[Abstract]. |
| 14. |
Gale, C. A.,
C. M. Bendel,
M. McClellan,
M. Hauser,
J. M. Becker,
J. Berman, and M. K. Hostetter.
1998.
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.
Science
279:1355-1358 |
| 15. |
Garrigues, J. C.,
G. Cadet de Fontenay,
M. D. Linas,
M. Lagente, and J. P. Seguela.
1994.
New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.
Antimicrob. Agents Chemother.
38:2857-2862 |
| 16. | Gillum, A. M., E. Y. H. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182[CrossRef][Medline]. |
| 17. | Gimeno, C. J., P. O. Ljungdahl, C. A. Styles, and G. R. Fink. 1992. Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell 68:1077-1090[CrossRef][Medline]. |
| 18. | Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272[CrossRef][Medline]. |
| 19. | Hube, B., M. Monod, D. A. Schofeild, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:87-99[CrossRef][Medline]. |
| 20. | Ishii, N., M. Yamamoto, F. Yoshihara, M. Arisawa, and Y. Aoki. 1997. Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicans. Microbiology 143:429-435[Abstract]. |
| 21. | Kobayashi, S. D., and J. E. Cutler. 1998. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol. 6:92-94[CrossRef][Medline]. |
| 22. |
Kumar, M. J.,
M. S. Jamaluddin,
K. Natarajan,
D. Kaur, and A. Datta.
2000.
The inducible N-acetylglucosamine catabolic pathway gene cluster in Candida albicans: discrete N-acetylglucosamine-inducible factors interact at the promoter of NAG1.
Proc. Natl. Acad. Sci. USA
97:14218-14223 |
| 23. |
Liu, H.,
J. Köhler, and G. R. Fink.
1994.
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.
Science
266:1723-1726 |
| 24. | Lo, H.-J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949[CrossRef][Medline]. |
| 25. |
Malathi, K.,
K. Ganesan, and A. Datta.
1994.
Identification of a putative transcription factor in Candida albicans that can complement the mating defect of Saccharomyces cerevisiae ste12 mutants.
J. Biol. Chem.
269:22945-22951 |
| 26. |
Mio, T.,
M. Kokado,
M. Arisawa, and H. Yamada-Okabe.
2000.
Reduced virulence of Candida albicans mutants lacking the GNA1 gene encoding glucosamine-6-phosphate acetyltransferase.
Microbiology
146:1753-1758 |
| 27. | Natarajan, K., Y. P. Rai, and A. Datta. 1984. Induction of N-acetyl-D-glucosamine catabolic enzymes and germinative response in Candida albicans. Biochem. Int. 9:735-744[Medline]. |
| 28. |
Natarajan, K., and A. Datta.
1993.
Molecular cloning and analysis of the NAG1 cDNA coding for glucosamine-6-phosphate deaminase from Candida albicans.
J. Biol. Chem.
268:9206-9214 |
| 29. | Odds, F. C. 1988. Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom. |
| 30. |
Plumbridge, J. A.
1990.
Induction of the nag regulon of Escherichia coli by N-acetylglucosamine and glucosamine: role of the cyclic AMP-catabolite activator protein complex in expression of the regulon.
J. Bacteriol.
172:2728-2735 |
| 31. | Rai, Y. P., and A. Datta. 1982. Induction of N-acetylglucosamine-6-phosphate deacetylase in yeast. Indian J. Biochem. Biophys. 19:285-287[Medline]. |
| 32. |
Riggle, P. J.,
K. A. Andrutis,
X. Chen,
S. R. Tzipori, and C. A. Kumamoto.
1999.
Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture.
Infect. Immun.
67:3649-3652 |
| 33. | Rotrosen, D., R. A. Calderone, and J. E. Edwards, Jr. 1986. Adherence of Candida species to host tissues and plastic surfaces. Rev. Infect. Dis. 8:73-85[Medline]. |
| 34. | Shepherd, M. G., C. Y. Yin, S. P. Ram, and P. A. Sullivan. 1980. Germ tube induction in Candida albicans. Can. J. Microbiol. 26:21-26[Medline]. |
| 35. | Shepherd, M. G., and P. A. Sullivan. 1983. Candida albicans germ-tube formation with immobilized GlcNAc. FEMS Microbiol. Lett. 17:167-170[CrossRef]. |
| 36. | Singh, B., and A. Datta. 1979. Induction of N-acetylglucosamine-catabolic pathway in spheroplasts of Candida albicans. Biochem. J. 178:427-431[Medline]. |
| 37. | Singh, B., and A. Datta. 1979. Regulation of N-acetylglucosamine uptake in yeast. Biochim. Biophys. Acta 557:248-258[Medline]. |
| 38. | Sonneborn, A., D. P. Bockmuhl, M. Gerads, K. Kurpanek, D. Sanglard, and J. F. Ernst. 2000. Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol. Microbiol. 35:386-396[CrossRef][Medline]. |
| 39. | Srikantha, T., B. Morrow, K. Schroppel, and D. R. Soll. 1995. The frequency of integrative transformation at phase-specific genes of Candida albicans correlates with their transcriptional state. Mol. Gen. Genet. 246:342-352[CrossRef][Medline]. |
| 40. | Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. F. Ernst. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982-1991[CrossRef][Medline]. |
| 41. | Sundstrom, P. 1999. Adhesins in Candida albicans. Curr. Opin. Microbiol. 2:353-357[CrossRef][Medline]. |
| 42. | Takahashi, M., Y. Banno, and Y. Nozawa. 1991. Secreted Candida albicans phospholipase: purification and characterization of two forms of lysophospholipase-transacylase. J. Med. Vet. Mycol. 29:193-204[Medline]. |
| 43. | Torosantucci, A., and A. Cassone. 1983. Induction and morphogenesis of chlamydospores in an agerminative variant of Candida albicans. Sabouraudia 21:49-57[Medline]. |
| 44. | Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|